2022 ESMO | ADaura Research Data Update: Early EGFR mutations positive NSCLC patients DFS continued to benefit significantly!
SummaryA few days ago, in 2022, the European Cancer Internal Science Association (...
Newly made new progress in lung cancer!Which patients can benefit?| 2022 WCLC
For medical professionals for reading referenceCome and learn!As immune and target...
ASCO "Martial Arts" value -added | CheckMate -274 Study MIBC Asian group data re -proved UC postoperative assist immunotherapy advantage
*For medical professionals for reading referenceThe survival period of no disease ...
Starting from the beginning, precision cure -the 5th Chinese breast cancer precision treatment summit forum · Surgery
*For medical professionals for reading referenceThe new auxiliary strategy adds to...